The Express Tribune45m
KSE-100 index drops on profit-booking
Meanwhile, pharmaceutical stocks continued their upward march, led by gains in Haleon, Abbott Laboratories and ...
BioPharma Dive7h
GSK partners with Flagship startup to hunt for Parkinson’s drugs
Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...
Ojjaara (momelotinib) approved in Canada for the treatment of myelofibrosis in adults who have moderate to severe anemia
CNW/ - GSK announced today that Health Canada has approved Ojjaara (momelotinib) for the treatment of splenomegaly and/or ...
Pharmaceutical Technology8h
Are dry powder inhalers the key to sustainable respiratory care?
Companies like AstraZeneca and GSK, which have high-revenue-generating inhalers for asthma and chronic obstructive pulmonary ...
Pharmabiz8h
ViiV Healthcare deepens its commitment to under-served LGBTI communities, pledging $7.8million in new funding
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, has announced it is pledging $7.8 million to the ‘Fund our Futures’ campaign led by ...
GlaxoSmithKline (GSK) was downgraded to a Hold Rating at Jefferies
In a report released today, Peter Welford from Jefferies downgraded GlaxoSmithKline (GSK – Research Report) to a Hold, with a price ...
Timor-Leste eliminates lymphatic filariasis as a public health problem
The Mectizan Donation Program applauds Timor-Leste for eliminating lymphatic filariasis (LF) as a public health problem, a ...
Hosted on MSN9h
GSK lowered to hold by Jefferies, valuation disconnect cited
Jefferies lowered GSK (NYSE:GSK) to hold, citing a valuation disconnect between fundamentals and price. Jefferies said it ...